Marksans Pharma Ltd
NSE:MARKSANS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Marksans Pharma Ltd
NSE:MARKSANS
|
IN |
|
I
|
Isracann Biosciences Inc
OTC:ISCNF
|
CA |
|
Noble Engineering Group Holdings Ltd
HKEX:8445
|
HK |
|
China Longyuan Power Group Corp Ltd
F:6WX0
|
CN |
|
Nippon Steel Corp
TSE:5401
|
JP |
|
F
|
FirstEnergy Corp
DUS:FE7
|
US |
|
A
|
Artmarket.com SA
F:AJP
|
FR |
|
F
|
First Mining Gold Corp
SWB:FMG
|
CA |
|
W
|
Whitbread PLC
DUS:WHF4
|
UK |
|
C
|
CJ Bioscience Inc
KOSDAQ:311690
|
KR |
|
T
|
TRC Construction PCL
SET:TRC
|
TH |
|
N
|
NetApp Inc
F:NTA
|
US |
|
S
|
Suumaya Industries Ltd
NSE:SUULD
|
IN |
|
P
|
Polight ASA
OSE:PLT
|
NO |
|
BlueRush Inc
XTSX:BTV
|
CA |
|
C
|
Clinuvel Pharmaceuticals Ltd
XMUN:UR9
|
AU |
|
P
|
Pacific Vegas Global Strategies Inc
OTC:PVEG
|
HK |
|
Christian Dior SE
PAR:CDI
|
FR |
Wall St Price Targets
MARKSANS Price Targets Summary
Marksans Pharma Ltd
According to Wall Street analysts, the average 1-year price target for MARKSANS is 299.88 INR with a low forecast of 212.1 INR and a high forecast of 396.9 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MARKSANS's stock price target?
Price Target
299.88
INR
According to Wall Street analysts, the average 1-year price target for MARKSANS is 299.88 INR with a low forecast of 212.1 INR and a high forecast of 396.9 INR.
What is the Revenue forecast for Marksans Pharma Ltd?
Projected CAGR
16%
Over the last 14 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 3 years is 16%.
What is the Gross Profit forecast for Marksans Pharma Ltd?
Projected CAGR
17%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 19%. The projected CAGR for the next 3 years is 17%.
What is the Operating Income forecast for Marksans Pharma Ltd?
Projected CAGR
28%
The compound annual growth rate for Operating Income over the next 3 years is 28%.
What is the Pre-Tax Income forecast for Marksans Pharma Ltd?
Projected CAGR
22%
The compound annual growth rate for Pre-Tax Income over the next 2 years is 22%.
What is the Net Income forecast for Marksans Pharma Ltd?
Projected CAGR
23%
The compound annual growth rate for Net Income over the next 3 years is 23%.
